Link to Pubmed [PMID] – 25677464
J Eur Acad Dermatol Venereol 2015 Feb;
The optimal management of Mycobacterium chelonae disease in immunocompromised patients remains unclear. A combination of antimicrobial agents is recommended as monotherapy with clarithromycin has been associated with clinical failures due to acquired resistance.